High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure.
Myoung Kyu LeeJaehwa ChoiBonil ParkBumjoon KimSeok Jeong LeeSang-Ha KimSuk Joong YongEun Hee ChoiWon-Yeon LeePublished in: The clinical respiratory journal (2018)
There was no difference of the 30-day mortality and intubation rate between HFNC and NIV groups.